Thursday, January 29, 2015 - In its most recent Hearing Session, the Judicial Panel on Multidistrict Litigation (JPML) approved the consolidation of national Xarelto lawsuits, according to court documents. Through the initial transfer order, the Panel approved the consolidation of twenty-one Xarelto lawsuits originating from 10 district courts spanning Florida, Illinois, Kentucky, Louisiana, New York, Utah, Vermont, and West Virginia. The cases have been transferred to the Eastern District of Louisiana for pretrial proceedings. The cases have been consolidated as MDL No. 2592, In Re: Xarelto (Rivaroxaban) Products Liability Litigation.
Plaintiffs in the initial Xarelto lawsuit actions suggested a wide range of transferee courts, according to the Transfer Order, including District Courts in Alabama, Colorado, Illinois, Florida, Georgia and New York in addition to Louisiana. The defendant opposed centralization, arguing that individual details regarding plaintiffs‘ medical histories made consolidation unfavorable, but suggested New Jersey as the transfer court should centralization move forward.
While differing medical histories were taken into account, the Judicial Panel on Multidistrict Litigation ultimately determined that the overriding commonalities of the cases made consolidation a practical choice, according to the transfer order. Specifically, the common issued cited include "the adequacy of Xarelto‘s warning label with respect to the risk of severe bleeding and other injuries, the results of certain clinical studies, and the alleged need for blood monitoring", according to the transfer order, on official court document.
In opposing consolidation, the defendant asserted that Xarelto lawsuit claims lack merit, and that consolidating the claims as an MDL would prompt many more persons to file "voluminous claims without due diligence", according to the transfer order. In response, the panel suggested that consolidation better facilitated the processing of "spurious claims", according to the court documents. Ultimately, the panel deemed multidistrict litigation would result in expediency and convenience for processing Xarelto lawsuits, according to court documents.
The defendant, Janssen Research & Development LLC, is a pharmaceutical company and a division of the global conglomerate Johnson & Johnson. According to the company‘s website, Janssen‘s goal is to "help people live healthy lives." The firm‘s headquarters are located in Titusville, New Jersey and became affiliated with Johnson & Johnson in 1961.
Lawyers representing clients nationwide in Xarelto bleeding lawsuits for the Onder Law Firm are now accepting claims from individuals and families of individuals who suffered from severe internal bleeding or hemorrhagic stroke and also have a history of taking Xarelto. Lawyers are investigating these inquiries for possible Xarelto lawsuits. The Onder Law Firm is renowned for its achievements in product and consumer safety litigation, with a strong track record of winning meaningful settlements for clients. The firm is nationally-renowned for its work on window blind strangulation, and has notable expertise in fighting on behalf of individuals against powerful corporations. Individuals and the family members of individuals who have suffered from internal bleeding and have taken Xarelto are eligible for a no-cost, no-obligation Xarelto lawsuit case review, and may contact the firm through its Xarelto Contingency Lawsuit website. The firm provides information on bleeding warnings and Xarelto lawsuit news.
The Onder Law Firm also welcomes Xarelto lawsuit inquiries from other law firms, either to handle these inquiries or work as co-counsel.
About The Onder Law Firm
Onder, Shelton, O‘Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O‘Leary & Peterson has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. It is a recognized leader in products liability cases such as window blind cord strangulation and pharmaceutical litigation. The Onder Law Firm‘s Xarelto attorneys provide information to the public at www.XareltoContingencyLawsuit.com.